HY-106961A-1mg
|
MedChemexpress LLC
|
(Z)-ONO 1301 [CAS 153814-74-5]
|
|
|
|
HY-106961A-5mg
|
MedChemexpress LLC
|
(Z)-ONO 1301 [CAS 153814-74-5]
|
|
|
|
HY-113465A-50ug
|
MedChemexpress LLC
|
11-trans Leukotriene E4 [CAS 75715-88-7]
|
|
COVID-19-immunoregulation
|
|
HY-103197-10mg
|
MedChemexpress LLC
|
2-Methoxyidazoxan (monohydrochloride) [CAS 109544-45-8]
|
|
Neuroscience-Neuromodulation
|
|
HY-103197-100mg
|
MedChemexpress LLC
|
2-Methoxyidazoxan (monohydrochloride) [CAS 109544-45-8]
|
|
Neuroscience-Neuromodulation
|
|
HY-103197-5mg
|
MedChemexpress LLC
|
2-Methoxyidazoxan (monohydrochloride) [CAS 109544-45-8]
|
|
Neuroscience-Neuromodulation
|
|
HY-103197-50mg
|
MedChemexpress LLC
|
2-Methoxyidazoxan (monohydrochloride) [CAS 109544-45-8]
|
|
Neuroscience-Neuromodulation
|
|
HY-50723-100mg
|
MedChemexpress LLC
|
3-Methylxanthine [CAS 1076-22-8]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-50723-1mL
|
MedChemexpress LLC
|
3-Methylxanthine [CAS 1076-22-8] (10mM in DMSO)
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-113442A-100ug
|
MedChemexpress LLC
|
6-trans-Leukotriene B4 [CAS 71652-82-9]
|
|
COVID-19-immunoregulation
|
|
HY-N0757-1mg
|
MedChemexpress LLC
|
8-?O-?Acetylharpagide [CAS 6926-14-3]
|
|
COVID-19-anti-virus
|
|
HY-N0757-10mg
|
MedChemexpress LLC
|
8-?O-?Acetylharpagide [CAS 6926-14-3]
|
|
COVID-19-anti-virus
|
|
HY-N0757-20mg
|
MedChemexpress LLC
|
8-?O-?Acetylharpagide [CAS 6926-14-3]
|
|
COVID-19-anti-virus
|
|
HY-N0757-5mg
|
MedChemexpress LLC
|
8-?O-?Acetylharpagide [CAS 6926-14-3]
|
|
COVID-19-anti-virus
|
|
HY-P1096-1mg
|
MedChemexpress LLC
|
A71623 [CAS 130408-77-4]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-P1096-10mg
|
MedChemexpress LLC
|
A71623 [CAS 130408-77-4]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-P1096-5mg
|
MedChemexpress LLC
|
A71623 [CAS 130408-77-4]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-70050C-10mg
|
MedChemexpress LLC
|
Alosetron (Hydrochloride) [CAS 122852-69-1]
|
|
Neuroscience-Neuromodulation
|
|
HY-70050C-100mg
|
MedChemexpress LLC
|
Alosetron (Hydrochloride) [CAS 122852-69-1]
|
|
Neuroscience-Neuromodulation
|
|
HY-70050C-5mg
|
MedChemexpress LLC
|
Alosetron (Hydrochloride) [CAS 122852-69-1]
|
|
Neuroscience-Neuromodulation
|
|
HY-70050C-50mg
|
MedChemexpress LLC
|
Alosetron (Hydrochloride) [CAS 122852-69-1]
|
|
Neuroscience-Neuromodulation
|
|
HY-70050C-1mL
|
MedChemexpress LLC
|
Alosetron (Hydrochloride) [CAS 122852-69-1] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
HY-13213-10mg
|
MedChemexpress LLC
|
AM211 [CAS 1175526-27-8]
|
|
COVID-19-immunoregulation
|
|
HY-13213-100mg
|
MedChemexpress LLC
|
AM211 [CAS 1175526-27-8]
|
|
COVID-19-immunoregulation
|
|
HY-13213-5mg
|
MedChemexpress LLC
|
AM211 [CAS 1175526-27-8]
|
|
COVID-19-immunoregulation
|
|